Nanotechnology approaches to addressing HER2-positive breast cancer

Nanotechnology approaches to addressing HER2-positive breast cancer

Abstract Breast cancer is a major cause of cancer-associated deaths in the United States. It was estimated that 12% of women in the U.S. will develop invasive breast cancer in their lifetime. The human epidermal growth factor receptor (HER2/neu) is a growth-promoting protein that is overexpressed in...

Full description

Bibliographic Details
Main Authors: Bryan E. White, Molly K. White, Het Adhvaryu, Issam Makhoul, Zeid A. Nima, Alexandru S. Biris, Nawab Ali
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Cancer Nanotechnology
Subjects:
HER2
Breast cancer
Nanotechnology
Targeting
Cellular uptake
Screening
Online Access:http://link.springer.com/article/10.1186/s12645-020-00068-2

Internet

http://link.springer.com/article/10.1186/s12645-020-00068-2

Similar Items